Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefano Rusconi

Showing results (71-80 of 192) with videos related to

Pageof 20
Sort By:
Journal of Medical Virology|March 31, 2020
Genomic characterization and phylogenetic analysis of SARS-COV-2 in ItalyGianguglielmo Zehender, Alessia Lai, Annalisa Bergna, et al.
HIV Medicine|June 5, 2024
Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapyVincenzo Malagnino, Alessandro Cozzi-Lepri, Valentina Svicher, et al.
Journal of Medical Virology|July 22, 2014
The role of baseline HIV-1 RNA, drug resistance, and regimen type as determinants of response to first-line antiretroviral therapyAntonio Di Biagio, Stefano Rusconi, Angela Marzocchetti, et al.
The Journal of Antimicrobial Chemotherapy|February 13, 2023
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA studyAntonella D'arminio Monforte, Alessandro Tavelli, Matteo Sala, et al.
AIDS (London, England)|November 15, 2023
Sexually transmitted infections in people with multidrug-resistant HIVTommaso Clemente, Riccardo Lolatto, Rebecka Papaioannu Borjesson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 17, 2021
Does Syphilis Increase the Risk of HIV-RNA Elevation >200 Copies/mL in HIV-Positive Patients Under Effective Antiretroviral Treatment? Data From the ICONA CohortAndrea Giacomelli, Alessandro Cozzi-Lepri, Antonella Cingolani, et al.
AIDS Reviews|February 3, 2012
Renal complications in HIV disease: between present and futurePaolo Maggi, Dario Bartolozzi, Paolo Bonfanti, et al.
Journal of the International AIDS Society|November 15, 2014
Atazanavir/ritonavir monotherapy as maintenance strategy in HIV-1 treated subjects with viral suppression: 96-week analysis results of the MODAT studyVincenzo Spagnuolo, Laura Galli, Alba Bigoloni, et al.
The New Microbiologica|May 21, 2013
Cross-sectional study of community serostatus to highlight undiagnosed HIV infections with oral fluid HIV-1/2 rapid test in non-conventional settingsMaria Rita Parisi, Laura Soldini, Gianmarino Vidoni, et al.
Antiviral Therapy|August 20, 2003
Virological success of lopinavir/ritonavir salvage regimen is affected by an increasing number of lopinavir/ritonavir-related mutationsMarco Bongiovanni, Teresa Bini, Fulvio Adorni, et al.
Pageof 20

Showing results (71-80 of 192) with videos related to

Sort By:
Pageof 20
Journal of Medical Virology|March 31, 2020
Genomic characterization and phylogenetic analysis of SARS-COV-2 in ItalyGianguglielmo Zehender, Alessia Lai, Annalisa Bergna, et al.
HIV Medicine|June 5, 2024
Association between markers of hepatitis B virus infection and risk of virological rebound in people with HIV receiving antiretroviral therapyVincenzo Malagnino, Alessandro Cozzi-Lepri, Valentina Svicher, et al.
Journal of Medical Virology|July 22, 2014
The role of baseline HIV-1 RNA, drug resistance, and regimen type as determinants of response to first-line antiretroviral therapyAntonio Di Biagio, Stefano Rusconi, Angela Marzocchetti, et al.
The Journal of Antimicrobial Chemotherapy|February 13, 2023
Long-term outcome of dolutegravir-containing regimens according to sex: data from the ICONA studyAntonella D'arminio Monforte, Alessandro Tavelli, Matteo Sala, et al.
AIDS (London, England)|November 15, 2023
Sexually transmitted infections in people with multidrug-resistant HIVTommaso Clemente, Riccardo Lolatto, Rebecka Papaioannu Borjesson, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|June 17, 2021
Does Syphilis Increase the Risk of HIV-RNA Elevation >200 Copies/mL in HIV-Positive Patients Under Effective Antiretroviral Treatment? Data From the ICONA CohortAndrea Giacomelli, Alessandro Cozzi-Lepri, Antonella Cingolani, et al.
AIDS Reviews|February 3, 2012
Renal complications in HIV disease: between present and futurePaolo Maggi, Dario Bartolozzi, Paolo Bonfanti, et al.
Journal of the International AIDS Society|November 15, 2014
Atazanavir/ritonavir monotherapy as maintenance strategy in HIV-1 treated subjects with viral suppression: 96-week analysis results of the MODAT studyVincenzo Spagnuolo, Laura Galli, Alba Bigoloni, et al.
The New Microbiologica|May 21, 2013
Cross-sectional study of community serostatus to highlight undiagnosed HIV infections with oral fluid HIV-1/2 rapid test in non-conventional settingsMaria Rita Parisi, Laura Soldini, Gianmarino Vidoni, et al.
Antiviral Therapy|August 20, 2003
Virological success of lopinavir/ritonavir salvage regimen is affected by an increasing number of lopinavir/ritonavir-related mutationsMarco Bongiovanni, Teresa Bini, Fulvio Adorni, et al.
Pageof 20